Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date How to Overcome UC&C and UCaaS Transformations That Impact Quality Performance Jason Chaffee, Senior Director, Product Marketing, NETSCOUT Eileen Haggerty, AVP, Product & Solutions Marketing, NETSCOUT Trends in UCaaS and UC&C transformations have potential for both beneficial and detrimental impacts. Learn techniques and approaches to reduce risk to... 7 days ago | 32 mins Reality vs. Hype: Lessons learned from Colt’s innovative Private 5G pilot Aaron Partouche, Colt Technology Services | Bill Queen, Keysight Technologies | Edouard Karam, Accedian Join this webinar to hear real experience and insights from deploying and assuring a Private 5G standalone network, one of the first in the real estat... 1 week ago | 61 mins How LiveCompare helps improve the quality of your custom SAP code Jonathan Boswell, Tim Girouard Bugs in your custom ABAP code can impact critical processes, costing your business time and money, and potentially damaging your reputation. These are... 1 month ago | 33 mins Streamline Investigations with Remote Collection of Androids and Workplace Apps Emmy Gamble, Technical Customer Success Manager, Cellebrite Enterprise Solution Secure remote collection and analysis of endpoint data is critical in today’s hybrid working environment. With employees generating more data than eve... 2 weeks ago | 41 mins Test Data Management: Leading Approaches, Best Practices, and Strategies Amitai Richman, TDM & Masking Director, K2View Despite the adoption of Lean-Agile thinking, modern engineering, and DevOps practices - test data management has lagged, leading to bottlenecks in pro... 4 weeks ago | 44 mins Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture... Dr John Metcalfe, Senior Pharmaceutical Quality Assessor at FDA and Dr. Doug Botkin at Charles River Laboratories Full title: Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture: Updates from a CDER Microbiologist's Perspective During this webin... 1 month ago | 121 mins Points to consider when defining a microbial control strategy... Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy) Full title: Points to consider when defining a microbial control strategy for individualized ATMPs How are individualized ATMPs different from tradit... 2 months ago | 55 mins Harmonized Manufacturing Network For Sterility Assurance Frederic Ayers at Eli Lilly and Company, Martell Winters at Nelson Labs and John Schlect at Sterigenics This presentation will provide an understanding related to Global Guidance related to holistic Contamination Control Strategies. The importance of cr... 4 months ago | 142 mins Corporate Sustainability Reporting Regulations – what are the implications? Dana Hanby, Carolynn Chalmers, Travis Miller, Juliette Gaussem, Susann Funke At the end of last year, the European Council gave its final approval to the Corporate Sustainability Reporting Directive (CSRD), which is a part of t... 2 months ago | 75 mins Global Regulatory Landscape and Indian Regulatory Framework of Car-T Therapies Presented by Yogananth Rajendran at Imuneel Therapeutics Private Limited Presented by Yogananth Rajendran, M. Pharm. RAC. Head - Regulatory Affairs and Quality Assurance (Cell and Gene therapy) at Immuneel Therapeutics The... July 14, 2023 8:30am Load more
